Urinary Infections Clinical Trial
Official title:
Study of the Safety and Efficacy of Piperacillin/Tazobactam in the Treatment of Patients With Complicated Urinary Infections.
The primary objective is to study the efficacy of piperacillin/tazobactam in patients with complicated urinary tract infections
| Status | Completed |
| Enrollment | 180 |
| Est. completion date | July 2007 |
| Est. primary completion date | July 2007 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 16 Years and older |
| Eligibility |
Inclusion Criteria: - Hospitalized patients over 16 years of age with complicated urinary infection produced by bacteria that are suspected to be susceptible to treatment with Piperacillin-tazobactam. Exclusion Criteria: - Patients known, or thought to be hypersensitivity to beta-lactams - Patients with an uncomplicated urinary tract infection |
Observational Model: Case-Only, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer |
Spain,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00560924 -
Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women
|
Phase 3 | |
| Recruiting |
NCT02658903 -
Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter
|
Phase 1 |